Reuters logo
BRIEF-Biogen Q3 earnings per share $5.79
2017年10月24日 / 上午11点15分 / 1 个月前

BRIEF-Biogen Q3 earnings per share $5.79

Oct 24 (Reuters) - Biogen Inc:

* Biogen reports quarterly revenues of $3.1 billion

* Q3 revenue $3.1 billion versus I/B/E/S view $3.04 billion

* Biogen Inc - ‍company restructures collaboration arrangements with eisai and neurimmune to improve long-term value of aducanumab​

* Biogen qtrly ‍ non-gaap diluted eps $ 6.31​

* Q3 earnings per share $5.79

* Biogen - qtrly tecfidera revenue of ‍$ 1,070​ million versus. $1,034 million

* Biogen - qtrly plegridy revenue of $‍​124 million versus $128 million last year

* Biogen - qtrly avonex revenue of $‍538​ million versus. $580 million

* Biogen - qtrly tysabri revenue of $‍​469 million versus $515 million last year

* Biogen - qtrly spinraza revenue of $‍271​ million versus. $203 million in q2

* Q3 earnings per share view $5.73 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below